Extracorporeal membrane oxygenation and inhaled sedation in coronavirus disease 2019-related acute respiratory distress syndrome
Martin Bellgardt, Dennis Özcelik, Andreas Breuer-Kaiser, Claudia Steinfort, Thomas Breuer, Thomas P. Weber, Jennifer Herzog‐Niescery
Abstract
, and each should be combined with a gas scavenging system. In this review, we describe respiratory management in COVID-19 patients and the procedures for inhaled sedation during ECMO therapy of COVID-19 related ARDS. We focus particularly on the technical details of administration of volatile anesthetics. Furthermore, we describe the advantages of inhaled sedation and volatile anesthetics, and we discuss the limitations as well as the requirements for safe application in the clinical setting.
Topics & Concepts
MedicineExtracorporeal membrane oxygenationARDSSedationIntensive care medicineAnesthesiaCoronavirus disease 2019 (COVID-19)LungDiseaseInternal medicineInfectious disease (medical specialty)Intensive Care Unit Cognitive DisordersAnesthesia and Sedative AgentsRespiratory Support and Mechanisms